Skip to main content
. 2018 Feb;9(1):1–10. doi: 10.21037/jgo.2017.10.14

Figure 2.

Figure 2

PFS curve on first line chemotherapy (Kaplan-Meier analysis). (A) Patients with wild type KRAS PDAC; (B) patients with mutant KRAS PDAC. PFS, progression free survival; PDAC, pancreatic ductal adenocarcinoma.